These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 9666170

  • 1. Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release.
    Angaut-Petit D, Molgó J, Faille L, Juzans P, Takahashi M.
    Brain Res; 1998 Jun 29; 797(2):357-60. PubMed ID: 9666170
    [Abstract] [Full Text] [Related]

  • 2. Mouse motor nerve terminal immunoreactivity to synaptotagmin II during sustained quantal transmitter release.
    Angaut-Petit D, Juzans P, Molgó J, Faille L, Seagar MJ, Takahashi M, Shoji-Kasai Y.
    Brain Res; 1995 May 29; 681(1-2):213-7. PubMed ID: 7552284
    [Abstract] [Full Text] [Related]

  • 3. Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle.
    Juzans P, Comella JX, Molgo J, Faille L, Angaut-Petit D.
    Neuromuscul Disord; 1996 May 29; 6(3):177-85. PubMed ID: 8784806
    [Abstract] [Full Text] [Related]

  • 4. Synaptotagmin II immunoreactivity in normal and botulinum type-A treated mouse motor nerve terminals.
    Juzans P, Molgo J, Faille L, Angaut-Petit D.
    Pflugers Arch; 1996 May 29; 431(6 Suppl 2):R283-4. PubMed ID: 8739375
    [Abstract] [Full Text] [Related]

  • 5. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions.
    Comella JX, Molgo J, Faille L.
    Neurosci Lett; 1993 Apr 16; 153(1):61-4. PubMed ID: 8390032
    [Abstract] [Full Text] [Related]

  • 6. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features.
    Angaut-Petit D, Molgó J, Comella JX, Faille L, Tabti N.
    Neuroscience; 1990 Apr 16; 37(3):799-808. PubMed ID: 1701041
    [Abstract] [Full Text] [Related]

  • 7. Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals.
    Santafé MM, Urbano FJ, Lanuza MA, Uchitel OD.
    Neuroscience; 2000 Apr 16; 95(1):227-34. PubMed ID: 10619479
    [Abstract] [Full Text] [Related]

  • 8. Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation.
    Meunier FA, Lisk G, Sesardic D, Dolly JO.
    Mol Cell Neurosci; 2003 Apr 16; 22(4):454-66. PubMed ID: 12727443
    [Abstract] [Full Text] [Related]

  • 9. Nerve-evoked synchronous release and high K+ -induced quantal events are regulated separately by synaptotagmin I at Drosophila neuromuscular junctions.
    Tamura T, Hou J, Reist NE, Kidokoro Y.
    J Neurophysiol; 2007 Jan 16; 97(1):540-9. PubMed ID: 17079341
    [Abstract] [Full Text] [Related]

  • 10. Release of packets of acetylcholine and synaptic vesicle elicited by brown widow spider venom in frog motor nerve endings poisoned by botulinum toxin.
    Pumplin DW, del Castillo J.
    Life Sci; 1975 Jul 01; 17(1):137-41. PubMed ID: 1079912
    [No Abstract] [Full Text] [Related]

  • 11. Low-frequency neuromuscular depression is a consequence of a reduction in nerve terminal Ca2+ currents at mammalian motor nerve endings.
    Silinsky EM.
    Anesthesiology; 2013 Aug 01; 119(2):326-34. PubMed ID: 23535502
    [Abstract] [Full Text] [Related]

  • 12. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.
    de Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO.
    Proc Natl Acad Sci U S A; 1999 Mar 16; 96(6):3200-5. PubMed ID: 10077661
    [Abstract] [Full Text] [Related]

  • 13. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J, del Pozo E, Baños JE, Angaut-Petit D.
    Br J Pharmacol; 1991 Sep 16; 104(1):133-8. PubMed ID: 1686201
    [Abstract] [Full Text] [Related]

  • 14. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF, Autio D, Rheuben MB, Atchison WD.
    J Neurophysiol; 2002 Dec 16; 88(6):3243-58. PubMed ID: 12466444
    [Abstract] [Full Text] [Related]

  • 15. Neurotransmitter secretion along growing nerve processes: comparison with synaptic vesicle exocytosis.
    Zakharenko S, Chang S, O'Donoghue M, Popov SV.
    J Cell Biol; 1999 Feb 08; 144(3):507-18. PubMed ID: 9971745
    [Abstract] [Full Text] [Related]

  • 16. Redistribution of synaptophysin and synapsin I during alpha-latrotoxin-induced release of neurotransmitter at the neuromuscular junction.
    Torri-Tarelli F, Villa A, Valtorta F, De Camilli P, Greengard P, Ceccarelli B.
    J Cell Biol; 1990 Feb 08; 110(2):449-59. PubMed ID: 1967610
    [Abstract] [Full Text] [Related]

  • 17. Synaptophysin (p38) at the frog neuromuscular junction: its incorporation into the axolemma and recycling after intense quantal secretion.
    Valtorta F, Jahn R, Fesce R, Greengard P, Ceccarelli B.
    J Cell Biol; 1988 Dec 08; 107(6 Pt 2):2717-27. PubMed ID: 3144557
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA.
    Hong SJ, Chang CC.
    J Physiol; 1995 Jan 15; 482 ( Pt 2)(Pt 2):283-90. PubMed ID: 7714822
    [Abstract] [Full Text] [Related]

  • 19. Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals.
    Flink MT, Atchison WD.
    J Pharmacol Exp Ther; 2003 May 15; 305(2):646-52. PubMed ID: 12606686
    [Abstract] [Full Text] [Related]

  • 20. Adrenaline Facilitates Synaptic Transmission by Synchronizing Release of Acetylcholine Quanta from Motor Nerve Endings.
    Khuzakhmetova V, Bukharaeva E.
    Cell Mol Neurobiol; 2021 Mar 15; 41(2):395-401. PubMed ID: 32274597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.